Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1974-7-15
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0091-6757
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
61
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
375-7
|
| pubmed:dateRevised |
2007-10-8
|
| pubmed:meshHeading |
pubmed-meshheading:4275140-Antibody Formation,
pubmed-meshheading:4275140-Azathioprine,
pubmed-meshheading:4275140-Cyclophosphamide,
pubmed-meshheading:4275140-DNA Replication,
pubmed-meshheading:4275140-Humans,
pubmed-meshheading:4275140-Immune Complex Diseases,
pubmed-meshheading:4275140-Immunity, Cellular,
pubmed-meshheading:4275140-Immunosuppressive Agents,
pubmed-meshheading:4275140-Methotrexate
|
| pubmed:year |
1974
|
| pubmed:articleTitle |
Use of immunosuppressant drugs in nonneoplastic disease.
|
| pubmed:publicationType |
Journal Article
|